Glutathione-Responsive Chemodynamic Therapy of Manganese(III/IV) Cluster Nanoparticles Enhanced by Electrochemical Stimulation via Oxidative Stress Pathway

Author(s):  
Yang Chen ◽  
Ming Chen ◽  
Tianli Zhai ◽  
Han Zhou ◽  
Zhiguo Zhou ◽  
...  
2009 ◽  
Vol 23 (2) ◽  
pp. 102-111 ◽  
Author(s):  
Arun K. Tiwari ◽  
Pushplata Prasad ◽  
Thelma B.K. ◽  
K.M. Prasanna Kumar ◽  
A.C. Ammini ◽  
...  

2020 ◽  
Author(s):  
Jianfeng Li ◽  
Shaoyu Hu ◽  
Song Hao ◽  
Shengjia Huang ◽  
Yi Qin ◽  
...  

Abstract Background The role of gene and pathway in recurrence of Ewing sarcoma (ES) was not clear. Thus, we investigated the biological role and underlying mechanism of gene and pathway in recurrence of ES. Methods Data sets of patients with ES were collected from the GEO database. We used dataset GSE63155 and GSE63156 to construct co-expression networks by weighted gene co-expression network analysis (WGCNA). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed by Database for Annotation, Visualization and Integrated Discovery (DAVID). Results We can find that genes with significant interactions in the genes of the recurrence group include SRSF11, TRIM39, SOCS3,NUPL2,COPS5. They work primarily through the oxidative stress pathway. Conclusion Through our research, for the first time found that ES by SRSF11 TRIM39, SOCS3, NUPL2, COPS5 interaction, activation of phosphorylation of bone and oxidative stress is affecting tumor recurrence.


Autophagy ◽  
2019 ◽  
Vol 16 (5) ◽  
pp. 917-931 ◽  
Author(s):  
Zhiqiang Deng ◽  
Junghyun Lim ◽  
Qian Wang ◽  
Kerry Purtell ◽  
Shuai Wu ◽  
...  

2019 ◽  
Vol 30 (12) ◽  
pp. 1365-1375
Author(s):  
Zhenzhen Zhang ◽  
Duo Jiang ◽  
Chi Wang ◽  
Mark Garzotto ◽  
Ryan Kopp ◽  
...  

2016 ◽  
Vol 21 (7) ◽  
pp. 680-688 ◽  
Author(s):  
Si Ho Choi ◽  
Darko Bosnakovski ◽  
Jessica M. Strasser ◽  
Erik A. Toso ◽  
Michael A. Walters ◽  
...  

Facioscapulohumeral muscular dystrophy is a genetically dominant, currently untreatable muscular dystrophy. It is caused by mutations that enable expression of the normally silent DUX4 gene, which encodes a pathogenic transcription factor. A screen based on Tet-on DUX4-induced mouse myoblast death previously uncovered compounds from a 44,000-compound library that protect against DUX4 toxicity. Many of those compounds acted downstream of DUX4 in an oxidative stress pathway. Here, we extend this screen to an additional 160,000 compounds and, using greater stringency, identify a new set of DUX4-protective compounds. From 640 hits, we performed secondary screens, repurchased 46 of the most desirable, confirmed activity, and tested each for activity against other cell death–inducing insults. The majority of these compounds also protected against oxidative stress. Of the 100 repurchased compounds identified through both screens, only SHC40, 75, and 98 inhibited DUX4 target genes, but they also inhibited dox-mediated DUX4 expression. Using a target gene readout on the 640-compound hit set, we discovered three overlooked compounds, SHC351, 540, and 572, that inhibit DUX4 target gene upregulation without nonspecific effects on the Tet-on system. These novel inhibitors of DUX4 transcriptional activity may thus act on pathways or cofactors needed by DUX4 for transcriptional activation in these cells.


Sign in / Sign up

Export Citation Format

Share Document